bf/NASDAQ:GILD_icon.png

NASDAQ:GILD

Gilead Sciences, Inc.

  • Stock

USD

Last Close

73.01

28/03 20:00

Market Cap

99.09B

Beta: 0.40

Volume Today

8.37M

Avg: 5.58M

PE Ratio

16.30

PFCF: 11.99

Dividend Yield

3.91%

Payout:48.14%

  • industry

    Drug Manufacturers / General
  • exchange

    NASDAQ Global Select
  • website

    www.gilead.com
  • ipo date

    Jan 01, 1992
  • full time employees

    17,000
  • currency

    USD

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla pro...Show More

Earnings

Earnings per Share (Estimate*)

0.511.522.533.52015-07-282017-07-262019-07-302021-07-292023-08-03

Revenue (Estimate*)

2B4B6B8B2015-07-282017-07-262019-07-302021-07-292023-08-03

*Estimate based on analyst consensus

investors

PartnersFunding RoundInvestor NameLead Investor
Post-IPO Equity - Gilead SciencesAbingworthYes
Seed Round - Gilead SciencesVenrock

investments

Money RaisedFunding RoundLead InvestorAnnounced DateOrganization Name
$320MPost-IPO Equity - Arcus BiosciencesYes29-01-2024Arcus Biosciences
A$21.3MPost-IPO Equity - Hookipa PharmaYes21-12-2023Hookipa Pharma
$15.2MPost-IPO Equity - Assembly BiosciencesYes17-10-2023Assembly Biosciences
$35MSeries B - Tentarix Biotherapeutics06-09-2023Tentarix Biotherapeutics
Corporate Round - Tentarix BiotherapeuticsYes15-08-2023Tentarix Biotherapeutics
$60MSeries B - Kyverna Therapeutics03-08-2023Kyverna Therapeutics
$8MGrant - CDA FoundationYes20-07-2023CDA Foundation
Grant - Power Safe Place Resource Center of VirginiaYes22-03-2023Power Safe Place Resource Center of Virginia
Grant - My Brother's KeeperYes22-03-2023My Brother's Keeper
Grant - Central Illinois FriendsYes22-03-2023Central Illinois Friends

acquisitions

PriceAcquiree NameAnnounced DateTransaction Name
XinThera09-05-2023XinThera acquired by Gilead Sciences
$405MMiroBio04-08-2022MiroBio acquired by Gilead Sciences
€1.5BMYR GmbH10-12-2020MYR GmbH acquired by Gilead Sciences
$21BImmunomedics13-09-2020Immunomedics acquired by Gilead Sciences
$4.9BForty Seven02-03-2020Forty Seven acquired by Gilead Sciences
$567MCell Design Labs07-12-2017Cell Design Labs acquired by Gilead Sciences
$11.9BKite Pharma28-08-2017Kite Pharma acquired by Gilead Sciences
Nimbus Apollo04-04-2016Nimbus Apollo acquired by Gilead Sciences
$65MEpitherapeutics06-05-2015Epitherapeutics acquired by Gilead Sciences
$470MPhenex Pharmaceuticals06-01-2015Phenex Pharmaceuticals acquired by Gilead Sciences

recent investments

Money RaisedFunding RoundLead InvestorAnnounced DateOrganization Name
$320MPost-IPO Equity - Arcus BiosciencesYes29-01-2024Arcus Biosciences
A$21.3MPost-IPO Equity - Hookipa PharmaYes21-12-2023Hookipa Pharma
$15.2MPost-IPO Equity - Assembly BiosciencesYes17-10-2023Assembly Biosciences
$35MSeries B - Tentarix Biotherapeutics06-09-2023Tentarix Biotherapeutics
Corporate Round - Tentarix BiotherapeuticsYes15-08-2023Tentarix Biotherapeutics
$60MSeries B - Kyverna Therapeutics03-08-2023Kyverna Therapeutics
$8MGrant - CDA FoundationYes20-07-2023CDA Foundation
Grant - Power Safe Place Resource Center of VirginiaYes22-03-2023Power Safe Place Resource Center of Virginia
Grant - My Brother's KeeperYes22-03-2023My Brother's Keeper
Grant - Central Illinois FriendsYes22-03-2023Central Illinois Friends

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.